http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3011058-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0923d641016cff6436e693f77d90b10d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de42b1abee683a84b8a078d6e9318e3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db9c3e1dcf2e7dd4ce4f8d4d5c881ff
publicationDate 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3011058-A1
titleOfInvention Circulating microrna based cancer biomarkers
abstract There is provided methods of diagnosing whether a subject has, or is at risk for developing, breast cancer, comprising measuring the level of miR-145, miR-107, and miR- 39-5p in a test sample from the subject and comparing the level of the miRNA in the test sample to the level of a corresponding miRNA in a control sample.
priorityDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505709
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386966
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994

Total number of triples: 25.